Compare AGEN to:
After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 0.67 |
|---|---|
| Trade Time: | 4:00pm ET |
| Change: | |
| Prev Close: | 0.69 |
| Open: | 0.69 |
| Bid: | 0.66 x 1400 |
| Ask: | 0.70 x 23000 |
| 1y Target Est: | 3.40 |
| Day's Range: | 0.66 - 0.70 |
|---|---|
| 52wk Range: | 0.19 - 3.34 |
| Volume: | 311,720 |
| Avg Vol (3m): | 1,526,570 |
| Market Cap: | N/A |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.37 |
| Div & Yield: | N/A (N/A) |
| Fri, Dec 18 | Biotech Stock Mailbag: Year in Reviewat TheStreet.com |
| Fri, Nov 20 | Antigenics pulls European Oncophage applicationAP |
| Fri, Nov 20 | ANTIGENICS INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online |
| Fri, Nov 20 | European CHMP Formally Adopts Negative Opinion on Oncophage®Business Wire |
| Fri, Nov 13 | ANTIGENICS INC /DE/ FinancialsEDGAR Online Financials |
| Mon, Nov 9 | ANTIGENICS INC /DE/ Files SEC form 10-Q, Quarterly ReportEDGAR Online |
| Fri, Nov 6 | 5 Cold Stocks Heating Upat Motley Fool |
| Wed, Nov 4 | ANTIGENICS INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online |
| Wed, Nov 4 | Antigenics Provides Details On GlaxoSmithKline's Pivotal Malaria Vaccine Trial With QS-21 AdjuvantBusiness Wire |
| Thu, Oct 29 | Antigenics Q3 2009 Earnings Call Transcriptat Seeking Alpha |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.